- Home
- KFFB vs BCTX Comparison
KFFB vs BCTX Comparison
Compare KFFB & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- BCTX
- Stock Information
- Founded
- KFFB 2005
- BCTX 2014
- Country
- KFFB United States
- BCTX Canada
- Employees
- KFFB N/A
- BCTX N/A
- Industry
- KFFB Savings Institutions
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- BCTX Health Care
- Exchange
- KFFB Nasdaq
- BCTX Nasdaq
- Market Cap
- KFFB 21.0M
- BCTX 23.5M
- IPO Year
- KFFB 2005
- BCTX N/A
- Fundamental
- Price
- KFFB $2.86
- BCTX $2.89
- Analyst Decision
- KFFB
- BCTX Strong Buy
- Analyst Count
- KFFB 0
- BCTX 1
- Target Price
- KFFB N/A
- BCTX $32.00
- AVG Volume (30 Days)
- KFFB 7.5K
- BCTX 324.8K
- Earning Date
- KFFB 05-12-2025
- BCTX 06-16-2025
- Dividend Yield
- KFFB N/A
- BCTX N/A
- EPS Growth
- KFFB N/A
- BCTX N/A
- EPS
- KFFB N/A
- BCTX N/A
- Revenue
- KFFB $8,308,000.00
- BCTX N/A
- Revenue This Year
- KFFB N/A
- BCTX N/A
- Revenue Next Year
- KFFB N/A
- BCTX N/A
- P/E Ratio
- KFFB N/A
- BCTX N/A
- Revenue Growth
- KFFB 13.79
- BCTX N/A
- 52 Week Low
- KFFB $1.96
- BCTX $2.78
- 52 Week High
- KFFB $3.62
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- KFFB 69.12
- BCTX 39.25
- Support Level
- KFFB $2.65
- BCTX $2.78
- Resistance Level
- KFFB $3.07
- BCTX $3.14
- Average True Range (ATR)
- KFFB 0.13
- BCTX 0.18
- MACD
- KFFB 0.03
- BCTX -0.01
- Stochastic Oscillator
- KFFB 74.15
- BCTX 16.15
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.